UBS lowered the firm’s price target on Estee Lauder (EL) to $75 from $107 and keeps a Neutral rating on the shares. The firm thinks Q1 results for much of the consumer staples group will be “okay” as organic revenue growth will show signs of improvement and stabilization, though the issue centers on how companies will handle forward looking commentary as inflation is likely to pose a greater risk to earnings in the second half and potentially beyond, the analyst tells investors in a preview for the group.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EL:
- Estee Lauder call volume above normal and directionally bullish
- Estee Lauder price target lowered to $108 from $124 at Deutsche Bank
- Somnigroup, Estee Lauder removed from from ‘US 1 List’ at BofA
- Estee Lauder price target lowered to $80 from $100 at Canaccord
- Buy Rating on Potential Estée Lauder–Puig Merger: Transformational Scale, Synergies, and Valuation Upside in Global Beauty